| Real-world Study to Describe the Effectiveness and Safety Outcomes of Jardiance in Chinese Patients With Heart Failure and Preserved Ejection Fraction (NCT07047508) | Boehringer Ingelheim | 2028-01-31 |
| Real-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection Fraction (NCT07044700) | Boehringer Ingelheim | 2028-01-31 |
| A Study to Test How Well Different Doses of BI 1831169 in Combination With an Anti-PD1 Antibody Are Tolerated in Japanese People With Different Advanced Cancers (NCT07176975) | Boehringer Ingelheim | 2027-08-03 |
| A Study to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body When Given by Injection in Healthy Men and Women With and Without Overweight or Obesity (NCT07768813) | Boehringer Ingelheim | 2026-09-01 |
| A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or Obesity (NCT07754474) | Boehringer Ingelheim | 2026-09-01 |
| A Study to Test How Well Different Doses of BI 3822971 Are Tolerated by People With Advanced Cancer (Solid Tumours) (NCT07744152) | Boehringer Ingelheim | 2026-08-31 |
| FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression (NCT07540988) | Boehringer Ingelheim | 2026-08-28 |
| DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers (NCT07707895) | Boehringer Ingelheim | 2026-08-26 |
| A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar (NCT07754461) | Boehringer Ingelheim | 2026-08-24 |
| A Study in Healthy People to Measure How Different Doses of Verducatib Affect the Heart (NCT07760246) | Boehringer Ingelheim | 2026-08-17 |
| A Study in Healthy People to Compare Two Tablet Formulations of Pramipexole (NCT07727785) | Boehringer Ingelheim | 2026-08-05 |
| Emotional and Social Experiences of Antifibrotic (AF) Therapy Among Idiopathic Pulmonary Fibrosis (IPF)/Progressive Pulmonary Fibrosis (PPF) Patients: A Real-World Study (NCT07743996) | Boehringer Ingelheim | 2026-08-01 |
| A Study to Test How BI 3034701 is Taken up and Processed by the Body in Healthy Men With Normal Weight or Overweight (NCT07708493) | Boehringer Ingelheim | 2026-07-29 |
| A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis (NCT07497087) | Boehringer Ingelheim | 2026-07-27 |
| A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Japanese Healthy People and Japanese People With Obesity or Overweight (NCT07693231) | Boehringer Ingelheim | 2026-07-21 |
| A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD) (NCT07366034) | Boehringer Ingelheim | 2026-07-21 |
| A Study in Japanese Healthy Men to Test How Well Different Doses of BI 3031185 Are Tolerated and a Study in Japanese Healthy Women to Test Whether BI 3031185 Influences the Amount of a Contraceptive in the Blood (NCT07656792) | Boehringer Ingelheim | 2026-07-17 |
| A Study in Healthy Men to Test How BI 1815368 is Processed in the Body (NCT07693218) | Boehringer Ingelheim | 2026-07-16 |
| DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy (NCT07544654) | Boehringer Ingelheim | 2026-07-10 |
| A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight (NCT07662122) | Boehringer Ingelheim | 2026-06-30 |
| A Study in Healthy Men to Test How Bosentan Influences the Amount of Zongertinib in the Blood (NCT07649941) | Boehringer Ingelheim | 2026-06-22 |
| A Study to Test How Verducatib is Taken up in the Body of Healthy Chinese Participants (NCT07531628) | Boehringer Ingelheim | 2026-06-10 |
| Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab (NCT07486817) | Boehringer Ingelheim | 2026-06-04 |
| A Study to Test How Different Doses of BI 3814916 Are Tolerated by Healthy People (NCT07486115) | Boehringer Ingelheim | 2026-05-20 |
| A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated (NCT07553429) | Boehringer Ingelheim | 2026-05-14 |
| A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab (NCT07607678) | Boehringer Ingelheim | 2026-05-01 |
| A Study to Test How BI 3000202 is Taken up in the Blood of People With and Without Liver Problems (NCT07486102) | Boehringer Ingelheim | 2026-05-01 |
| A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours) (NCT07306559) | Boehringer Ingelheim | 2026-04-28 |
| A Study in Healthy People to Test How Vicadrostat Affects the Heart (NCT07513207) | Boehringer Ingelheim | 2026-04-22 |
| A Study in Healthy Men to Test How Well Different Doses of BI 3821001 Are Tolerated (NCT07526194) | Boehringer Ingelheim | 2026-04-22 |
| A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE) (NCT07409181) | Boehringer Ingelheim | 2026-04-20 |
| DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy (NCT07472517) | Boehringer Ingelheim | 2026-04-13 |
| A Study to Test Different Doses of BI 3923948 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors) (NCT07395258) | Boehringer Ingelheim | 2026-04-02 |
| Spesolimab Post-marketing Surveillance in Korean Patients With Flares With Generalized Pustular Psoriasis (NCT06886009) | Boehringer Ingelheim | 2026-03-31 |
| PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease (NCT07355296) | Boehringer Ingelheim | 2026-03-23 |
| A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body (NCT07407348) | Boehringer Ingelheim | 2026-03-11 |
| A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood (NCT06241560) | Boehringer Ingelheim | 2026-03-05 |
| A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like Injector (NCT07413913) | Boehringer Ingelheim | 2026-03-03 |
| A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH) (NCT07325526) | Boehringer Ingelheim | 2026-02-27 |
| A Study of BI 3810944 in Patients With Advanced Cancer (NCT07224425) | Boehringer Ingelheim | 2026-02-24 |
| A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well (NCT07361302) | Boehringer Ingelheim | 2026-02-17 |
| A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis (NCT07201922) | Boehringer Ingelheim | 2026-02-10 |
| A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 764198 in the Blood (NCT07308652) | Boehringer Ingelheim | 2026-02-09 |
| A Study in Healthy People to Test Whether BI 764198 Influences the Amount of Metformin in the Body (NCT07368569) | Boehringer Ingelheim | 2026-02-06 |
| A Study in Healthy Men to Test How BI 1584862 is Processed in the Body (NCT07336758) | Boehringer Ingelheim | 2026-01-22 |
| Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations (NCT07195695) | Boehringer Ingelheim | 2026-01-16 |
| A Study in Healthy Men and Women to Test How BI 3000202 is Taken up and Processed by the Body (NCT07273474) | Boehringer Ingelheim | 2025-12-30 |
| A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids) (NCT07107945) | Boehringer Ingelheim | 2025-12-09 |
| A Study in Healthy Men to Find Out How Different Doses of BI 3009947 Are Tolerated and How Different Formulations or Food Influence How BI 3009947 is Taken up Into the Blood (NCT07250048) | Boehringer Ingelheim | 2025-11-21 |
| A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment (NCT07036523) | Boehringer Ingelheim | 2025-11-13 |
| A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body (NCT07221591) | Boehringer Ingelheim | 2025-11-05 |
| A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body (NCT07215260) | Boehringer Ingelheim | 2025-11-05 |
| A Study in Healthy People to Test How Itraconazole Influences the Amount of BI 3031185 in the Blood (NCT07211425) | Boehringer Ingelheim | 2025-10-08 |
| Real-World Treatment Patterns and Outcomes in HER2-Altered Metastatic Breast Cancer Patients in the United States (NCT07342309) | Boehringer Ingelheim | 2025-09-30 |
| A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases (NCT06806592) | Boehringer Ingelheim | 2025-09-13 |
| A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Blood (NCT07133399) | Boehringer Ingelheim | 2025-09-08 |
| A Study in Healthy Men to Test How Bosentan Influences the Amount of Nerandomilast in the Blood (NCT07081932) | Boehringer Ingelheim | 2025-08-26 |
| A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Nerandomilast in the Blood (NCT07100964) | Boehringer Ingelheim | 2025-08-11 |
| A Study to Test How BI 1584862 is Taken up in the Blood of People With and Without Liver Problems (NCT06957756) | Boehringer Ingelheim | 2025-08-06 |
| A Study to Test How BI 1819479 is Taken up and Processed by the Body (NCT07065617) | Boehringer Ingelheim | 2025-08-04 |
| A Study to Test How Well BI 3000202 is Tolerated by People With Type 1 Interferonopathies (NCT06878365) | Boehringer Ingelheim | 2025-07-29 |
| A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body (NCT07071974) | Boehringer Ingelheim | 2025-07-28 |
| SGLT2 Inhibitors and Renal Anemia in Japan: RWD (NCT07063316) | Boehringer Ingelheim | 2025-07-23 |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease (NCT07064473) | Boehringer Ingelheim | 2025-07-22 |
| A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver Problems (NCT07023354) | Boehringer Ingelheim | 2025-07-17 |
| A Study in Healthy Men to Compare the Amount of Vicadrostat and Empagliflozin in the Blood When Taken Separately and Together (NCT07035457) | Boehringer Ingelheim | 2025-07-02 |
| The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take Nintedanib (NCT06912659) | Boehringer Ingelheim | 2025-06-23 |
| A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung Fibrosis (NCT07080125) | Boehringer Ingelheim | 2025-06-17 |
| The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis (NCT06872892) | Boehringer Ingelheim | 2025-06-09 |
| A Study to Test How Well Multiple Doses of BI 3810477 Are Tolerated by Healthy Adults (NCT06984926) | Boehringer Ingelheim | 2025-06-06 |
| A Study in Healthy People to Test How Empagliflozin is Taken up in the Body When Taken as a Whole Tablet or Dissolved in Water and Mixed With Food (NCT06962826) | Boehringer Ingelheim | 2025-05-27 |
| A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI 3720931 (Lenticlair™-ON) (NCT06962852) | Boehringer Ingelheim | 2025-05-20 |
| A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart (NCT06935370) | Boehringer Ingelheim | 2025-05-20 |
| A Study in Healthy People to Test How 3 Different Formulations of BI 764198 Are Taken up in the Body and How This is Influenced by Food (NCT06955754) | Boehringer Ingelheim | 2025-05-20 |
| A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone (NCT06806852) | Boehringer Ingelheim | 2025-05-14 |
| A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the Blood (NCT06917872) | Boehringer Ingelheim | 2025-04-29 |
| A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men and Women (NCT06916702) | Boehringer Ingelheim | 2025-04-07 |
| A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas (NCT06882746) | Boehringer Ingelheim | 2025-03-28 |
| A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity (NCT06745284) | Boehringer Ingelheim | 2025-03-26 |
| A Study in Healthy Men to Test Whether Food Influences the Amount of BI 3731579 in the Blood (NCT06861829) | Boehringer Ingelheim | 2025-03-19 |
| A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body (NCT06772532) | Boehringer Ingelheim | 2025-02-10 |
| A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy (NCT06769048) | Boehringer Ingelheim | 2025-01-31 |
| A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated (NCT06745297) | Boehringer Ingelheim | 2025-01-23 |
| A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia (NCT06791122) | Boehringer Ingelheim | 2025-01-23 |
| A Study in Healthy People to Test Whether BI 1291583 Influences the Amount of Dabigatran in the Body (NCT06791187) | Boehringer Ingelheim | 2025-01-23 |
| A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH (NCT06675929) | Boehringer Ingelheim | 2025-01-20 |
| A Study to Test How Zongertinib is Taken up in the Blood of People With and Without Liver Problems (NCT06692322) | Boehringer Ingelheim | 2025-01-15 |
| A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy (NCT06722157) | Boehringer Ingelheim | 2025-01-06 |
| A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine (NCT06619509) | Boehringer Ingelheim | 2024-12-30 |
| A Study to Test How Different Doses of BI 3731579 Are Tolerated by Healthy People (NCT06716190) | Boehringer Ingelheim | 2024-12-18 |
| A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis (NCT06636656) | Boehringer Ingelheim | 2024-12-11 |
| A Study in Healthy People to Test How 2 Different Formulations of BI 690517 Are Taken up in the Body and How Probenecid Influences the Amount of BI 690517 in the Blood (NCT06647810) | Boehringer Ingelheim | 2024-11-13 |
| A Study in Healthy Men to Test Whether BI 1815368 Influences the Amount of Metformin in the Body (NCT06655220) | Boehringer Ingelheim | 2024-11-08 |
| LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis (NCT06632457) | Boehringer Ingelheim | 2024-11-07 |
| A Study to Test How Well BI 3720931 is Tolerated and Whether it Improves Lung Function in People With Cystic Fibrosis (Lenticlair™ 1) (NCT06515002) | Boehringer Ingelheim | 2024-11-04 |
| A Study to Test How Well Different Doses of BI 3810477 Are Tolerated by Healthy Men (NCT06631430) | Boehringer Ingelheim | 2024-10-30 |
| A Study in Healthy People to Test How 2 Different Doses of BI 1291583 Are Taken up in the Body When Given in 3 Different Formulations (NCT06631417) | Boehringer Ingelheim | 2024-10-22 |
| Post Marketing Surveillance of JARDIANCE in Chronic Kidney Disease (NCT06527846) | Boehringer Ingelheim | 2024-10-22 |
| A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy (NCT06528093) | Boehringer Ingelheim | 2024-10-16 |
| Real-life-persistence to Antifibrotic Treatments (NCT06485635) | Boehringer Ingelheim | 2024-10-16 |